Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT06264180
A Randomized, Controlled, Multicenter, Phase 3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination with Nivolumab Versus Treatment of Physicians Choice in Patients with Advanced Melanoma That Has Progressed on an Anti-PD-1 and an Anti-CTLA-4 Containing Treatment Regimen [IGNYTE-3] RP-1
Status
Open
Conditions
Melanoma, skin
Phases
3 (Cancer Control)
Age Group
Adult
Main Investiagtor
Chouliaras, Konstantinos
Practice
Melanoma
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT06264180
Secondary Trial ID Number
RP1-104
Keywords
Treatment